昭衍新药(06127)获董事姚大林累计减持1.51万股减持计划尚未实施完毕

智通财经2022-06-20

智通财经APP讯，昭衍新药(06127)公布，该公司董事姚大林披露减持计划前持有公司股份6.89万股，占当时的持股比例为0.018%。上述股份来源于股权激励股份及公司资本公积金转增股份等其他方式。姚大林拟自减持计划公告之日起15个交易日后(即5月25日起)的6个月内，通过上海证券交易所集中竞价的交易方式减持不超过1.72万股，不超过公司当时总股本的0.0045%。截止本公告披露日，姚大林减持...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2244184064?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2022-06-20 16:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2244184064","market":"hk","top_or_hot":-1,"title":"昭衍新药(06127)获董事姚大林累计减持1.51万股 减持计划尚未实施完毕","media":"智通财经","content":"<div>\n<p>智通财经APP讯，昭衍新药(06127)公布，该公司董事姚大林披露减持计划前持有公司股份6.89万股，占当时的持股比例为0.018%。上述股份来源于股权激励股份及公司资本公积金转增股份等其他方式。姚大林拟自减持计划公告之日起15个交易日后(即5月25日起)的6个月内，通过上海证券交易所集中竞价的交易方式减持不超过1.72万股，不超过公司当时总股本的0.0045%。截止本公告披露日，姚大林减持...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/741308.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昭衍新药(06127)获董事姚大林累计减持1.51万股 减持计划尚未实施完毕</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昭衍新药(06127)获董事姚大林累计减持1.51万股 减持计划尚未实施完毕\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-20 16:55 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/741308.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，昭衍新药(06127)公布，该公司董事姚大林披露减持计划前持有公司股份6.89万股，占当时的持股比例为0.018%。上述股份来源于股权激励股份及公司资本公积金转增股份等其他方式。姚大林拟自减持计划公告之日起15个交易日后(即5月25日起)的6个月内，通过上海证券交易所集中竞价的交易方式减持不超过1.72万股，不超过公司当时总股本的0.0045%。截止本公告披露日，姚大林减持...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/741308.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1576","symbol_name":"医药外包概念","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/741308.html","article_id":"2244184064","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2244184064","pubTimestamp":1655715357,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，昭衍新药(06127)公布，该公司董事姚大林披露减持计划前持有公司股份6.89万股，占当时的持股比例为0.018%。上述股份来源于股权激励股份及公司资本公积金转增股份等其他方式。姚大林拟自减持计划公告之日起15个交易日后(即5月25日起)的6个月内，通过上海证券交易所集中竞价的交易方式减持不超过1.72万股，不超过公司当时总股本的0.0045%。截止本公告披露日，姚大林减持1.51万股。减持计划尚未实施完毕。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603127":"昭衍新药","BK1576":"医药外包概念","06127":"昭衍新药","BK1141":"生命科学工具和服务"},"translate_title":"Zhaoyan New Drug (06127) has been reduced by Yao Dalin, the director, and the reduction plan of 15,100 shares has not yet been implemented","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603127":1,"06127":1},"content_text":"智通财经APP讯，昭衍新药(06127)公布，该公司董事姚大林披露减持计划前持有公司股份6.89万股，占当时的持股比例为0.018%。上述股份来源于股权激励股份及公司资本公积金转增股份等其他方式。姚大林拟自减持计划公告之日起15个交易日后(即5月25日起)的6个月内，通过上海证券交易所集中竞价的交易方式减持不超过1.72万股，不超过公司当时总股本的0.0045%。截止本公告披露日，姚大林减持1.51万股。减持计划尚未实施完毕。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2244184064"}

昭衍新药(06127)获董事姚大林累计减持1.51万股 减持计划尚未实施完毕

精彩评论

昭衍新药(06127)获董事姚大林累计减持1.51万股减持计划尚未实施完毕